Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer|July 23, 2003
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trialsJohn F R Robertson, C Kent Osborne, Anthony Howell, et al.Cancer|November 3, 2011
Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in AmericaTracy Spinks, Heidi W Albright, Thomas W Feeley, et al.International Journal of Radiation Oncology, Biology, Physics|April 12, 2014
Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatmentAndrew McBride, Pamela Allen, Wendy Woodward, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2008
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECTStephen Chia, William Gradishar, Louis Mauriac, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifenMitch Dowsett, Jack Cuzick, Jim Ingle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trialMitch Dowsett, Craig Allred, Jill Knox, et al.Cancer Research|January 6, 2010
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitorsLiewei Wang, Katarzyna A Ellsworth, Irene Moon, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2026
Definitive, stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers: A prospective, phase II trialSimona F Shaitelman, Savitri Krishnamurthy, Heather Lin, et al.Pageof 3